Compound formula for adjusting surface mucous layer barrier of digestive tract and respiratory tract

A pipeline and mucus technology, applied in the field of amino acid combination formula, can solve problems such as large side effects and unsatisfactory effects

Inactive Publication Date: 2016-06-15
何松庆
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory in effect and have large side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0023] 1. 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine are made into granules, 2 to 4 times a day.

[0024] 2. 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cystine are made into granules, 2 to 4 times a day.

[0025] 3. 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine are made into medicines, 2 to 4 times a day.

[0026] 4. 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cystine are made into medicines, 2 to 4 times a day.

[0027] 5. 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine are made into oral liquid, 2 to 4 times a day.

[0028] Sixth, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cystine are made into oral liquid, 2 to 4 times a day.

[0029] 7. Take 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine as oral preparations, 2 to 4 times a day.

[0030] Eight, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cys...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound formula for adjusting the surface mucous layer barrier of a digestive tract and a respiratory tract, belonging to the field of medicines. The compound formula disclosed by the invention consists of threonine, serine, cysteine and cystine. The compound formula disclosed by the invention provides raw materials for the mucoprotein secretion of the mucous cells such as goblet cells and mucous glands of the digestive tract and respiratory tract, and is an effective compound formula for establishing a normal surface mucous layer barrier of the digestive tract and respiratory tract of a human body, preventing antigens from approaching, touching, adhering to and entering the tissues of the digestive tract and respiratory tract, blocking the occurrence of abnormal immune response, terminating inflammation, repairing the tissues of the digestive tract and respiratory tract and preventing and treating the diseases of the digestive system and respiratory system.

Description

technical field [0001] The invention relates to a combination formula of amino acids and belongs to the field of medicines. Background technique [0002] Most human diseases occur or originate in the digestive system and respiratory system, especially inflammatory bowel disease (inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) in the digestive system and chronic bronchitis (chronicbronchitis) in the respiratory system. Asthma (bronchialasthma) and other diseases whose etiology and pathogenesis have not yet been fully clarified. Since the cause and pathogenesis of these diseases have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the course of these diseases. [0003] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. [0004] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/198A61P1/00A61P11/00A61P11/06
CPCA61K31/198A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products